MDM2 contributes to oxidized low-density lipoprotein-induced inflammation through modulation of mitochondrial damage in endothelial cells.

BACKGROUND AND AIMS: Murine double minute-2 (MDM2) has been poorly studied in cardiovascular diseases. The aim of the present study was to determine the biological role of MDM2 in inflammation activation and mitochondrial damage in human aortic endothelial cells (HAECs) stimulated with oxidized low-density lipoprotein (ox-LDL).

METHODS

The expression of MDM2 in the aortas of atherosclerotic mice was determined. An adenoviral vector for MDM2 overexpression and siRNA for MDM2 downregulation were constructed and used to transfect HAECs. The functional changes in HAECs stimulated by ox-LDL were observed.

RESULTS

The protein expression of MDM2 was increased in atherosclerotic mice and ox-LDL-treated HAECs. In addition, ox-LDL-induced mRNA expression and secretion of TNF-α, IL-6 and IL-1β were significantly decreased by MDM2 downregulation and increased by MDM2 overexpression, and activation of NF-κB and caspase-1 was involved in the activity of MDM2. The ox-LDL-induced mitochondrial damage, indicated as increase in mitochondrial ROS production, decrease in mitochondrial membrane potential and elevation of mitochondrial DNA release, was significantly reversed by MDM2 downregulation and worsened by MDM2 overexpression. The ox-LDL-induced activation of TLR9/NF-κB and NLRP3/caspase-1 pathway was inhibited by MDM2 downregulation and worsened by MDM2 overexpression. The aggravation caused by MDM2 overexpression was abolished by mito-TEMPO. Treatment with mito-TEMPO significantly reduced the increase in mRNA expression and secretion of TNF-α, IL-6 and IL-1β induced by MDM2 overexpression in ox-LDL treated HAECs.

CONCLUSIONS

These findings suggest that MDM2 contributes to ox-LDL-induced inflammation via regulating mitochondrial damage.